Diabetes: Debiotech takes out option on iSense

Debiotech grabs an option for exclusive rights to continuous glucose monitoring sensors made by iSense CGM for its disposable insulin patch pump.

Switzerland's Debiotech wants to blend continuous glucose monitoring technology made by an Oregon outfit into its JewelPump disposable insulin patch pump, a move toward a functioning artificial pancreas.

The Lausanne-based company announced an option to grab exclusive rights to CGM intellectual property developed by iSense CGM of Wilsonville, Ore.

Debiotech, iSense CGM

News Well, Diabetes, Insulin Management

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1J6n8Ej